TANDEM DIABETES CARE INC
TNDM
DELAYED 1 MONTH

26 insider filings · Latest: Jun 2, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Mar 5, 2026Mar 9 8:27 PMMark David NovaraEVP & CHIEF COMMERCIAL OFFICER
Sale
2$22.81$4635,969(D)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 21, 2026May 22 8:06 PMChristopher J TwomeyDirector
Option Exercise
8,759—0(D)

View →

May 20, 2026May 22 8:06 PMChristopher J TwomeyDirector
Grant/Award
10,220—10,220(D)

View →

May 21, 2026May 22 8:04 PMMyoungil ChaDirector
Option Exercise
8,759—0(D)

View →

May 20, 2026May 22 8:04 PMMyoungil ChaDirector
Grant/Award
10,220—10,220(D)

View →

May 15, 2026May 19 8:15 PMRick CarpenterEVP & Chief Technology Officer
Option Exercise
8,774—12,878(D)

View →

May 15, 2026May 19 8:13 PMElizabeth Anne GasserEVP, Chief Strategy Officer
Option Exercise
10,267—15,335(D)

View →

May 15, 2026May 19 8:12 PMShannon Marie HansenEVP & Chief Legal Officer
Option Exercise
10,201—15,335(D)

View →

May 15, 2026May 19 8:10 PMJean-Claude KyrillosEVP & Chief Operating Officer
Option Exercise
4,038—8,077(D)

View →

May 15, 2026May 19 8:08 PMSusan MorrisonEVP & Chief Admin. Officer
Option Exercise
9,523—13,845(D)

View →

May 15, 2026May 19 8:06 PMJohn F SheridanDirector, PRESIDENT & CEO
Option Exercise
51,189—79,471(D)

View →

May 15, 2026May 19 8:03 PMLeigh VossellerEVP & CHIEF FINANCIAL OFFICER
Option Exercise
13,495—20,992(D)

View →

May 15, 2026May 19 8:02 PMMark David NovaraEVP & CHIEF COMMERCIAL OFFICER
Option Exercise
10,572—20,992(D)

View →

← Previous

Page 2 of 2